ATARA BIOTHERAPEUTICS, INC. Employee Count
The employee counts ATARA BIOTHERAPEUTICS, INC. states in its annual reports on SEC EDGAR, each as filed.
- 2024-12-31: Employees (as filed) 153; Filing 2025-03-07; Lease expense per employee $120,313.73.
- 2023-12-31: Employees (as filed) 225; Filing 2024-03-28; Lease expense per employee $83,488.89.
- 2022-12-31: Employees (as filed) 334; Filing 2023-02-08; Lease expense per employee $47,532.93.
- 2021-12-31: Employees (as filed) 578; Filing 2022-02-28; Lease expense per employee $8,539.79.
- Available history
- 2017-12-31 to 2024-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2024-12-31 | 153 | 2025-03-07 | $120,313.73 operating + short-term + finance amortization + finance interest |
| 2023-12-31 | 225 | 2024-03-28 | $83,488.89 operating + short-term + finance amortization + finance interest |
| 2022-12-31 | 334 | 2023-02-08 | $47,532.93 operating + short-term + finance amortization + finance interest |
| 2021-12-31 | 578 | 2022-02-28 | $8,539.79 operating + short-term + finance amortization + finance interest |
| 2020-12-31 | 437 | 2021-03-01 | $10,196.80 operating + short-term + finance amortization + finance interest |
| 2019-12-31 | 393 | 2020-02-27 | $9,486.01 operating + short-term + finance amortization + finance interest |
| 2018-12-31 | 311 | 2019-02-26 | $7,073.95 rent expense, net |
| 2017-12-31 | 185 full-time | 2018-02-27 | $7,567.57 rent expense, net |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |